Critical Path Institute® (C-Path) celebrates its 20th anniversary as a vital, independent, trusted nonprofit that generates solutions to facilitate scientific and regulatory pathways that accelerate the development of therapies for people with unmet medical needs. With a proven track record of success, C-Path has established numerous international consortia, programs and initiatives that currently include more than 1,600 scientists and representatives from government and regulatory agencies, academia, patient organizations, disease foundations, and pharmaceutical and biotech companies. Our cross-cutting methodologies and disease-specific expertise ensure our solutions have broad applicability while addressing the distinct challenges of individual diseases.